SECONDARY HYPERPARATHYROIDISM
Clinical trials for SECONDARY HYPERPARATHYROIDISM explained in plain language.
Never miss a new study
Get alerted when new SECONDARY HYPERPARATHYROIDISM trials appear
Sign up with your email to follow new studies for SECONDARY HYPERPARATHYROIDISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids on dialysis: drug targets overactive glands
Disease control Recruiting nowThis phase 3 trial tests the drug etelcalcetide (Parsabiv) in 24 children aged 2 to 17 with secondary hyperparathyroidism due to chronic kidney disease who are on hemodialysis. The goal is to see if the drug can safely lower parathyroid hormone levels and improve mineral balance.…
Matched conditions: SECONDARY HYPERPARATHYROIDISM
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New hope for kids on dialysis: drug targets hormone imbalance
Disease control Recruiting nowThis phase 3 trial tests etelcalcetide (Parsabiv) in 56 children aged 28 days to under 18 years who have secondary hyperparathyroidism and chronic kidney disease and are on hemodialysis. The drug aims to lower parathyroid hormone levels and improve mineral balance. Participants r…
Matched conditions: SECONDARY HYPERPARATHYROIDISM
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New blood test could end painful bone biopsies for kidney disease patients
Knowledge-focused Recruiting nowThis study is testing whether a blood test that looks at tiny genetic molecules called microRNAs can accurately detect bone problems in people with chronic kidney disease. Currently, doctors rely on a bone biopsy, which is invasive and not practical for most patients. The researc…
Matched conditions: SECONDARY HYPERPARATHYROIDISM
Sponsor: Thomas Nickolas • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
New blood test may reveal bone health in kids on dialysis
Knowledge-focused Recruiting nowThis study tests a new, non-invasive method using calcium isotope ratios in blood to see if the drug cinacalcet improves bone calcium balance in children aged 3-17 who are on dialysis and have secondary hyperparathyroidism. Researchers will measure these ratios before and three m…
Matched conditions: SECONDARY HYPERPARATHYROIDISM
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC